Clinical characteristics of coronavirus disease 2019 in patients undergoing laparoscopic bariatric/metabolic surgery: a nationwide survey in Japan.

IF 1.7 4区医学 Q2 SURGERY

Surgery Today Pub Date : 2024-12-03 DOI:10.1007/s00595-024-02967-y

Yasuhiro Miyazaki, Masayuki Ohta, Seiichi Kitahama, Yosuke Seki, Susumu Inamine, Takashi Oshiro, Yoshihiro Nagao, Fumihiko Hatao, Hajime Orita, Akira Sasaki, Shunsuke Kagawa, Tsuyoshi Yamaguchi, Keiji Aizu, Keiji Hayata, Shin Saito, Manabu Amiki, Yoji Nakamura, Hisahiro Matsubara, Mitsuo Shimada, Takeshi Naitoh, Nobuya Ishibashi, Shuji Takiguchi, Kazunori Shibao, Kentaro Inoue, Takeshi Togawa, Takuro Saito, Kohei Uno, Yuichi Endo, Kazunori Kasama, Ichiro Tatsuno

{"title":"Clinical characteristics of coronavirus disease 2019 in patients undergoing laparoscopic bariatric/metabolic surgery: a nationwide survey in Japan.","authors":"Yasuhiro Miyazaki, Masayuki Ohta, Seiichi Kitahama, Yosuke Seki, Susumu Inamine, Takashi Oshiro, Yoshihiro Nagao, Fumihiko Hatao, Hajime Orita, Akira Sasaki, Shunsuke Kagawa, Tsuyoshi Yamaguchi, Keiji Aizu, Keiji Hayata, Shin Saito, Manabu Amiki, Yoji Nakamura, Hisahiro Matsubara, Mitsuo Shimada, Takeshi Naitoh, Nobuya Ishibashi, Shuji Takiguchi, Kazunori Shibao, Kentaro Inoue, Takeshi Togawa, Takuro Saito, Kohei Uno, Yuichi Endo, Kazunori Kasama, Ichiro Tatsuno","doi":"10.1007/s00595-024-02967-y","DOIUrl":null,"url":null,"abstract":"Purpose: Bariatric/metabolic surgery has been reported to reduce the incidence of severe coronavirus disease 2019 (COVID-19); however, its ability to reduce risk is controversial. Therefore, this study aimed to elucidate the incidence and severity of COVID-19 in bariatric patients in Japan.Methods: The first survey of patients infected with COVID-19 after bariatric/metabolic surgery until June 30, 2022, was sent to 83 Japanese institutions. A second survey was conducted in institutions that reported on COVID-19 patients. The severity of COVID-19 was compared between the general population and bariatric patients, and risk factors correlated with severity were also evaluated.Results: Twenty-six institutions (31.3%) reported 119 patients with COVID-19 after laparoscopic bariatric/metabolic surgery. There were no severe cases or deaths; however, moderate COVID-19 (pneumonia) was significantly more common in bariatric patients than in the general population (11.4% vs. 1.3%). The risk factors for moderate COVID-19 in bariatric patients included incurable dyslipidemia and infection before the 6th wave of the pandemic.Conclusion: In Japan, the number of moderate COVID-19 cases may be higher in bariatric patients than in the general population. This study did not show that bariatric/metabolic surgery reduces the risk of COVID-19 complications.","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery Today","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00595-024-02967-y","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: Bariatric/metabolic surgery has been reported to reduce the incidence of severe coronavirus disease 2019 (COVID-19); however, its ability to reduce risk is controversial. Therefore, this study aimed to elucidate the incidence and severity of COVID-19 in bariatric patients in Japan.

Methods: The first survey of patients infected with COVID-19 after bariatric/metabolic surgery until June 30, 2022, was sent to 83 Japanese institutions. A second survey was conducted in institutions that reported on COVID-19 patients. The severity of COVID-19 was compared between the general population and bariatric patients, and risk factors correlated with severity were also evaluated.

Results: Twenty-six institutions (31.3%) reported 119 patients with COVID-19 after laparoscopic bariatric/metabolic surgery. There were no severe cases or deaths; however, moderate COVID-19 (pneumonia) was significantly more common in bariatric patients than in the general population (11.4% vs. 1.3%). The risk factors for moderate COVID-19 in bariatric patients included incurable dyslipidemia and infection before the 6th wave of the pandemic.

Conclusion: In Japan, the number of moderate COVID-19 cases may be higher in bariatric patients than in the general population. This study did not show that bariatric/metabolic surgery reduces the risk of COVID-19 complications.

查看原文本刊更多论文

2019冠状病毒病在腹腔镜减肥/代谢手术患者中的临床特征：日本的一项全国性调查

目的：有报道称减肥/代谢手术可降低2019年严重冠状病毒病（COVID-19）的发病率；然而，它降低风险的能力是有争议的。因此，本研究旨在阐明日本肥胖患者中COVID-19的发病率和严重程度。方法：对截至2022年6月30日的减肥/代谢手术后感染COVID-19的患者进行首次调查，调查对象为日本83家机构。在报告新冠肺炎患者的机构中进行了第二次调查。比较普通人群和肥胖患者的COVID-19严重程度，并评估与严重程度相关的危险因素。结果：26家机构（31.3%）报告了119例腹腔镜减肥/代谢手术后的COVID-19患者。没有严重病例或死亡；然而，中度COVID-19（肺炎）在肥胖患者中比在普通人群中更常见（11.4%对1.3%）。肥胖患者中出现中度COVID-19的危险因素包括无法治愈的血脂异常和第六波大流行之前的感染。结论：在日本，肥胖患者中新冠肺炎中度病例数可能高于普通人群。该研究并未显示减肥/代谢手术可降低COVID-19并发症的风险。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Surgery Today 医学-外科

CiteScore

4.90

自引率

4.00%

发文量

208

审稿时长

1 months

期刊介绍： Surgery Today is the official journal of the Japan Surgical Society. The main purpose of the journal is to provide a place for the publication of high-quality papers documenting recent advances and new developments in all fields of surgery, both clinical and experimental. The journal welcomes original papers, review articles, and short communications, as well as short technical reports("How to do it"). The "How to do it" section will includes short articles on methods or techniques recommended for practical surgery. Papers submitted to the journal are reviewed by an international editorial board. Field of interest: All fields of surgery.